| Literature DB >> 33925201 |
Kashaf Junaid1, Hasan Ejaz1, Iram Asim2, Sonia Younas3, Humaira Yasmeen2, Abualgasim Elgaili Abdalla1, Khalid Omer Abdalla Abosalif1, Ayman Ali Mohammed Alameen1, Naveed Ahmad4, Syed Nasir Abbas Bukhari5, Abdul Rehman6.
Abstract
This study evaluates bacteriological profiles in ready-to-eat (RTE) foods and assesses antibiotic resistance, extended-spectrum β-lactamase (ESBL) production by gram-negative bacteria, and heavy metal tolerance. In total, 436 retail food samples were collected and cultured. The isolates were screened for ESBL production and molecular detection of ESBL-encoding genes. Furthermore, all isolates were evaluated for heavy metal tolerance. From 352 culture-positive samples, 406 g-negative bacteria were identified. Raw food samples were more often contaminated than refined food (84.71% vs. 76.32%). The predominant isolates were Klebsiella pneumoniae (n = 76), Enterobacter cloacae (n = 58), and Escherichia coli (n = 56). Overall, the percentage of ESBL producers was higher in raw food samples, although higher occurrences of ESBL-producing E. coli (p = 0.01) and Pseudomonas aeruginosa (p = 0.02) were observed in processed food samples. However, the prevalence of ESBL-producing Citrobacter freundii in raw food samples was high (p = 0.03). Among the isolates, 55% were blaCTX-M, 26% were blaSHV, and 19% were blaTEM. Notably, heavy metal resistance was highly prevalent in ESBL producers. These findings demonstrate that retail food samples are exposed to contaminants including antibiotics and heavy metals, endangering consumers.Entities:
Keywords: ESBL; beta-lactamase; food contaminants; heavy metals; processed food
Year: 2021 PMID: 33925201 PMCID: PMC8124721 DOI: 10.3390/ijerph18094718
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Types of food samples collected and processed in this study (n = 436).
Gram-negative isolates from processed and raw food samples (n = 408).
| Isolates ( | Processed Food Samples ( | Raw Food Samples ( | |
|---|---|---|---|
| 38 (20.43%) | 18 (8.11%) | <0.01 | |
| 32 (17.20%) | 44 (19.82%) | 0.49 | |
| 22 (11.83%) | 36 (16.22%) | 0.20 | |
| 16 (8.60%) | 13 (5.86%) | 0.28 | |
| 14 (7.53%) | 5 (2.25%) | 0.01 | |
| 14 (7.53%) | 21 (9.46%) | 0.48 | |
| 13 (6.99%) | 8 (3.60%) | 0.12 | |
| 11 (5.91%) | 32 (14.41%) | 0.01 | |
| 11 (5.91%) | 27 (12.16%) | 0.03 | |
| 9 (4.84%) | 8 (3.60%) | 0.53 | |
| 6 (3.23%) | 10 (4.50%) | 0.50 |
p-values were obtained from the chi-square test.
Antimicrobial resistance profiles of food isolates (n = 408).
| Antibiotics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ampicillin | IR | IR | 41 | 32 | IR | 26 | IR | IR | IR | 9 | 11 |
| 73.21% | 74.42% | 74.29% | 52.94% | 68.75% | |||||||
| Aztreonam | 19 | 23 | 16 | 15 | 12 | 21 | 9 | 10 | 8 | 4 | 6 |
| 25% | 39.66% | 28.57% | 34.88% | 31.58% | 60% | 31.03% | 47.62% | 42.11% | 23.53% | 37.5% | |
| Amikacin | 24 | 26 | 19 | 13 | 19 | 27 | 9 | 9 | 8 | 4 | 7 |
| 31.58% | 44.83% | 33.93% | 30.23% | 50% | 77.14% | 31.03% | 42.86% | 42.11% | 23.53% | 43.75% | |
| Gentamicin | 21 | 24 | 16 | 12 | 19 | 27 | 8 | 7 | 4 | 7 | |
| 27.63% | 41.38% | 28.57% | 27.91% | 50% | 77.14% | 31.03% | 38.10% | 36.84% | 23.53% | 43.75% | |
| Cefuroxime | 28 | 29 | 19 | 15 | IR | 13 | IR | 11 | 9 | 7 | 8 |
| 36.84% | 50% | 33.93% | 34.88% | 37.14% | 52.38% | 47.37% | 41.18% | 50% | |||
| Cefoxitin | 19 | IR | 17 | 19 | IR | 12 | IR | 9 | 8 | 2 | 1 |
| 25% | 30.36% | 44.19% | 34.29% | 42.86% | 42.11% | 11.76% | 6.25% | ||||
| Ceftriaxone | 21 | 34 | 19 | 15 | 19 | 21 | 9 | 11 | IR | 7 | 3 |
| 27.63% | 58.62% | 33.93% | 34.88% | 50% | 60% | 31.03% | 52.38% | 41.18% | 18.75% | ||
| Ceftazidime | 23 | 35 | 21 | 17 | 19 | 27 | 9 | 11 | 8 | 7 | 7 |
| 30.26% | 60.34% | 37.50% | 39.53% | 50% | 77.14% | 31.03% | 52.38% | 42.11% | 41.18% | 43.75% | |
| Cefotaxime | 24 | 32 | 25 | 26 | 17 | 18 | 17 | 11 | IR | 9 | 8 |
| 31.58% | 55.17% | 44.64% | 60.47% | 44.74% | 51.43% | 58.62% | 52.38% | 52.94% | 50% | ||
| Cefepime | 17 | 7 | 16 | 6 | 4 | 16 | 3 | 7 | 2 | 5 | |
| 22.37% | 12.07% | 28.57% | 13.95% | 10.53% | 45.71% | 10.34% | 33.33% | 10.53% | 23.53% | 31.25% | |
| Ciprofloxacin | 17 | 9 | 11 | 7 | 4 | 7 | 3 | 5 | 2 | 5 | 3 |
| 22.37% | 15.52% | 19.64% | 16.28% | 10.53% | 20% | 10.34% | 23.81% | 10.53% | 29.41% | 18.75% | |
| Levofloxacin | 19 | 12 | 10 | 7 | 3 | 6 | 3 | 4 | 2 | 5 | 3 |
| 25% | 20.69% | 17.86% | 16.28% | 7.89% | 17.14% | 10.34% | 19.05% | 10.53% | 29.41% | 18.75 | |
| Imipenem | 17 | 6 | 13 | 6 | 4 | 7 | 3 | 5 | 2 | 3 | 3 |
| 22.37% | 10.34% | 23.21% | 13.95% | 10.53% | 20% | 10.34% | 23.81% | 10.53% | 17.65% | 18.75% | |
| Meropenem | 1 | 6 | 12 | 6 | 4 | 8 | 3 | 5 | 2 | 3 | 3 |
| 23.68% | 10.34% | 21.43% | 13.95 | 10.53% | 22.86% | 10.34% | 23.81% | 10.53% | 17.65% | 18.75% | |
| Piperacillin-Tazobactam | 1 | 6 | 5 | 6 | 4 | 3 | 4 | 2 | 3 | 3 | |
| 15.79% | 10.34% | 8.93% | 13.95% | 10.53% | 22.86% | 10.34% | 19.05% | 10.53% | 17.65% | 18.75% | |
| Colistin | 1 | 2 | 1 | IR | 1 | 0 | 1 | 0 | 0 | IR | |
| 1.32% | 1.72% | 3.57% | 2.33% | 2.86% | 0.00 | 4.76% | 0% | 0% | |||
| Co-trimoxazole | 22 | 21 | 16 | 15 | 12 | 14 | 9 | 10 | 8 | 4 | 6 |
| 28.95% | 36.21% | 28.57% | 34.88% | 31.58% | 40% | 31.03% | 47.62% | 42.11% | 23.53% | 37.5% | |
| Tigecycline | 7 | 3 | 2 | 6 | 2 | 1 | 1 | 1 | IR | 1 | IR |
| 9.21% | 5.17% | 3.57% | 13.95% | 5.26% | 2.86% | 3.45% | 4.76% | 5.88% |
IR: intrinsic resistance.
Gram-negative isolates from processed and raw food samples (n = 408).
| Isolates ( | Processed Food ( | Raw Food ( | OR (95% CI) | |
|---|---|---|---|---|
| 17 (43.59%) | 22 (56.41%) | 0.53 | 0.8 (0.39–1.63) | |
| 6 (37.50%) | 10 (62.50%) | 0.37 | 0.62 (0.22–1.8) | |
| 24 (66.67%) | 12 (33.33%) | 0.01 | 2.64 (1.22–5.72) | |
| 8 (47.06%) | 9 (52.94%) | 0.93 | 0.96 (0.35–2.62) | |
| 2 (28.57%) | 5 (71.43%) | 0.29 | 0.42 (0.08–2.22) | |
| 5 (45.45%) | 6 (54.55%) | 0.86 | 0.9 (0.26–3.06) | |
| 3 (21.43%) | 11 (78.57%) | 0.03 | 3.71 (1.52–12.50) | |
| 2 (40%) | 3 (60%) | 0.69 | 0.72 (0.12–4.1) | |
| 11 (78.57%) | 3 (21.43%) | 0.02 | 4.43 (1.19–12.60) | |
| 3 (75%) | 1 (25%) | 0.273 | 3.34 (0.34–31.74) | |
| 3 (30%) | 7 (70%) | 0.24 | 0.44 (0.11–1.78) |
OR: odds ratio; CI: confidence interval; p-values were obtained from the chi-square test, and odds ratios were obtained by regression analysis.
Figure 2Genetic distribution of ESBL-encoding genes in the isolates (n = 150).
Distributions of ESBL bla gene variants (n = 150).
| CTX-M-1 (56, 37.33%) | 17 (47.22%) | 5 (35.71%) | 11 (34.38%) | 6 (37.5%) | 1 (20%) | 3 (30%) | 3 (27.27%) | 2 (66.67%) | 4 (33.33%) | 1 (33.33%) |
| CTX-M-2 (21, 14%) | 3 (8.33%) | 2 (14.29%) | 6 (18.75%) | 2 (12.5%) | 1 (20%) | 1 (10%) | 2 (18.18%) | 0 (0%) | 2 (16.67%) | 1 (33.33%) |
| CTX-M-9 (6, 4%) | 2 (5.56%) | 1 (7.14%) | 1 (3.13%) | 0 (0%) | 0 (0%) | 1 (10%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| TEM-1 (25, 16.67%) | 8 (22.22%) | 3 (21.43%) | 6 (18.75%) | 1 (6.25%) | 1 (20%) | 2 (20%) | 2 (18.18%) | 0 (0%) | 2 (16.67%) | 0 (0%) |
| TEM-135 (2, 1.33%) | 1 (2.78%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (9.09%) | 0 (0%) | 0 (0%) | 0 (0%) |
| TEM-4 (1, 0.67%) | 0 (0%) | 1 (7.14%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| SHV-12 (35, 23.33%) | 5 (13.89%) | 2 (14.29%) | 7 (21.88%) | 5 (31.25%) | 2 (40%) | 3 (30%) | 3 (27.27%) | 1 (33.33%) | 3 (25%) | 1 (33.33%) |
| SHV-11 (4, 2.67%) | 0 (0%) | 0 (0%) | 1 (3.13%) | 2 (12.5%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (8.33%) | 0 (0%) |
Figure 3Number of heavy metal resistant isolates at different concentrations of heavy metals. As the concentration of heavy metal increased, the number of organisms decreased. (a) High resistance trend of ESBL producers against Cadmium. (b) High resistance trend of ESBL producers against Chromium. (c) High resistance trend of ESBL producers against Molybdinieum (d) High resistance trend of ESBL producers against Arsenic.